Skip to main content
. 2017 Jun 27;8(38):63084–63095. doi: 10.18632/oncotarget.18647

Figure 6. MTA3 is the target of miR-367.

Figure 6

(A) Bioinformatics prediction was showed. (B and C) The protein levels of MTA3 in 786-O and Caki-1 cell lines were analyzed by western blotting. (D and E) The mRNA level of MTA3 was measured by qRT-PCR. Overexpression of miR-367 could inhibit the mRNA expression of MTA3. Data are expressed as mean ± SEM. *p<0.05 vs. miR-control.